Vienna, VIENNA4 Active Studies

Ankylosing Spondylitis Clinical Trials in Vienna, VIENNA

Find 4 actively recruiting ankylosing spondylitis clinical trials in Vienna, VIENNA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
434
Enrolling

Recruiting Ankylosing Spondylitis Studies in Vienna

RecruitingVienna, VIENNANCT04752774

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

The purpose of the study is to assess the safety and efficacy of increasing doses of IPN10200 with the aim to evaluate the Pharmacodynamics (PD) profile of IPN10200 and to establish the total IPN10200...

240 participants
Ipsen
View Study Details
RecruitingVienna, VIENNANCT04844606

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks ...

150 participants
Eli Lilly and Company
View Study Details
RecruitingVienna, VIENNANCT06116136

A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.

This study will investigate the safety, tolerability, and antitumor activity of S095029 (anti-NKG2A antibody) in combination with pembrolizumab in in microsatellite instability-high/Defective mismatch...

32 participants
Servier Bio-Innovation LLC
View Study Details
RecruitingVienna, VIENNANCT04833894

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

The purpose of this trial is to investigate the PK, PD, safety, and activity of efgartigimod IV in children and adolescents aged from 2 to less than 18 years of age with gMG. Trial details include: ...

12 participants
argenx
View Study Details

About Ankylosing Spondylitis Clinical Trials in Vienna

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Vienna, VIENNA. These studies are seeking a combined 434 participants. Research is being sponsored by Ipsen, Eli Lilly and Company, Servier Bio-Innovation LLC and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Vienna — FAQ

Are there ankylosing spondylitis clinical trials in Vienna?

Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Vienna, VIENNA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Vienna?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Vienna research site will contact you about next steps.

Are clinical trials in Vienna free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Vienna studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 4 active trials in Vienna are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov